Table 2. Th lymphocyte subsets in patients with VKH disease.
Characteristics | Active VKH patients | Inactive VKH patients | Healthy controls | aP | bP | cP |
Th1 | 23.42±5.98 | 13.57±7.00 | 17.58±6.60 | 0.03 | 0.17 | 0.01 |
Th2 | 1.64±0.79 | 2.54±1.79 | 2.04±0.81 | 0.23 | 0.46 | 0.06 |
Th1/Th2 | 14.3±7.16 | 7.38±5.65 | 8.45±3.68 | 0.02 | 0.35 | 0.02 |
Th17 | 37.47±14.53 | 17.23±9.87 | 25.97±5.35 | 0.001 | 0.05 | 0.03 |
Treg | 2.00±1.77 | 4.26±1.70 | 5.60±2.06 | 0.04 | 0.08 | 0.04 |
Th17/Treg | 10.63±3.35 | 7.84±6.35 | 4.81±1.66 | 0.001 | 0.06 | 0.04 |
VKH: Vogt-Koyanagi-Harada. aHealthy controls vs active patients; bHealthy controls vs inactive patients; cActive patients vs inactive patients.
mean±SD, pg/mL